Studies: Inflammation-Targeting Antibody Boosts Preterm Birth Outcomes, Prevents Obesity-Linked Liver Disease
Targeting a master regulator of inflammation with a monoclonal antibody potentially improves two unrelated conditions with limited treatment options: preterm births and fatty liver disease, two new studies show.
